Access Vascular
MA - BillericaBiotechnology
Focus: Access Vascular is a pre-revenue medical device biotech focused on hydrogel-based venous access catheters for cardiovascular applications. The company operates at micro-scale (1-50 employees) with a focused pipeline of midline and PICC catheter programs.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Employees
1-50
Open Jobs
3
Should You Work at Access Vascular?
AI assessmentHigh-risk, early-stage device play suitable only for impact-driven candidates comfortable with uncertainty and equity-dependent compensation.
Why Work Here
- Early-stage venture with potential to shape the venous access device category—rare opportunity to influence product architecture from inception
- Focused pipeline on practical clinical unmet need (midline and PICC complications) with direct path to patient impact
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Hydrophilic Biomaterial Catheter
Midline CatheterHydrophilic Biomaterial PICC
Peripheral ICCHydroPICC
Help build intelligence for Access Vascular
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.